Invention Grant
- Patent Title: Multifunctional antibodies binding to EGFR and MET
- Patent Title (中): 多功能抗体结合EGFR和MET
-
Application No.: US14573373Application Date: 2014-12-17
-
Publication No.: US09328173B2Publication Date: 2016-05-03
- Inventor: Hector Aldaz , Barrett Allan , Ling Liu , Jirong Lu , Ying Tang , Sheng-Hung Rainbow Tschang , Pia Pauliina Yachi
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Robert L. Sharp
- Main IPC: C07K16/40
- IPC: C07K16/40 ; C07K16/28 ; C07K16/30 ; A61K39/00
Abstract:
Provided are multifunctional antibodies, and/or antigen-binding fragments, that bind to, and inhibit the activity of, both human epidermal growth factor receptor (EGFR) and MET, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by EGFR and MET.
Public/Granted literature
- US20150175708A1 Multifunctional Antibodies Binding to EGFR and MET Public/Granted day:2015-06-25
Information query
